Telomir Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Director Del Giudice Matthew Paul
Telomir Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Director Whalen Matthew Pratt
Telomir Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Officer Aminov Erez
Telomir Pharmaceuticals | 10-Q: Q2 2024 Earnings Report
Telomir Pharmaceuticals | 8-K: Current report
Telomir Pharmaceuticals | 10-Q: Quarterly report
Telomir Pharmaceuticals | 8-K: Current report
Telomir Pharmaceuticals | 8-K: Current report
Telomir Pharmaceuticals | 10-K: FY2023 Annual Report
Telomir Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-10% Owner Bay Shore Trust
Telomir Pharmaceuticals | 8-K: Current report
Telomir Pharmaceuticals | 424B4: Prospectus
Telomir Pharmaceuticals | 424B1: Prospectus
Telomir Pharmaceuticals | EFFECT: Others
Telomir Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-10% Owner Bay Shore Trust
Telomir Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Director Tuck Talhia
Telomir Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Officer Fuentes Nathen
Telomir Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Director Jerman Michael Allen
Telomir Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Director McColl Hugh III
Telomir Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Director EAGLE CRAIG
No Data